Male Hypogonadism: Reading the Brain–Testis Axis in Blood

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Blood testing for male hypogonadism maps the brain–testis axis through testosterone, free testosterone, bioavailable testosterone, LH, and FSH—identifying whether low androgen output reflects testicular failure (primary; high LH/FSH) or impaired pituitary signaling (secondary; low/normal LH/FSH). Two morning samples confirm diagnosis. Tracking these five markers is associated with bone density, body composition, mood, and fertility—providing a pathway to precise evaluation and long-term risk monitoring.

Read more →

Understand what your hormone testing results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Male hypogonadism and the brain–testis axis on a lab report

Male hypogonadism biomarkers are blood signals that map how well the brain–testis system is supplying and delivering male hormones. They help confirm whether androgen activity is adequate and show where any slowdown is occurring—at the testes themselves or higher up in the control center. Core markers include testosterone (the main androgen made by testicular Leydig cells), free testosterone (the unbound, bioactive fraction), and sex hormone–binding globulin or SHBG (the carrier protein that sets hormone availability). Pituitary messengers—luteinizing hormone, LH (the driver of Leydig cells), and follicle‑stimulating hormone, FSH (the driver of Sertoli cells and sperm development)—reveal the brain’s stimulation of the testes. Prolactin (a pituitary hormone) and estradiol (an aromatized form of testosterone) show feedback forces that can dampen this axis. Inhibin B (a Sertoli cell product) reflects spermatogenic activity. Together, these biomarkers provide a coherent picture of androgen supply, tissue‑ready hormone, pituitary drive, and sperm‑support function, enabling precise diagnosis, fertility assessment, and targeted treatment monitoring in male hypogonadism.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why confirming low T matters before acting

Male hypogonadism testing looks at the brain–testis axis—total testosterone, free and bioavailable testosterone, and the pituitary signals LH and FSH. These markers reflect how well your body maintains vitality across systems: sexual function and fertility, muscle and bone building, mood and cognition, red blood cell production, and metabolic health. In healthy adult men, morning total testosterone typically sits in the mid‑to‑upper portion of a lab’s reference range. Free testosterone is the small active fraction (about 1–3% of total), and bioavailable testosterone (free plus albumin‑bound) is roughly a third to a half of total; both often track best with symptoms and tend to feel optimal in the middle of their ranges. LH and FSH usually rest in the low‑to‑mid normal range when feedback is intact. With age, values drift lower; during puberty they rise into adult ranges. When testosterone is low with high LH/FSH, the testes are underperforming (primary hypogonadism); when testosterone is low with low or inappropriately normal LH/FSH, the brain signals are weak (secondary hypogonadism). Effects can include low libido, fewer morning erections, erectile difficulties, fatigue, low mood, reduced muscle and strength, increased visceral fat, anemia, decreased bone density and fracture risk, and infertility. Teen boys may show delayed puberty and slow growth. Big picture: these labs connect reproductive hormones to bone, blood, brain, and metabolism. Persistently low androgen signaling is linked to osteoporosis, anemia, adverse body composition, insulin resistance, depressive symptoms, and reduced quality of life, making accurate blood testing central to diagnosis and long‑term risk assessment.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

What hormone testing settles — and what it leaves open

Male hypogonadism blood testing provides a window into the hormonal systems that drive energy, metabolism, cardiovascular health, cognition, reproduction, and immune function. At Superpower, we measure testosterone, free testosterone (Free T), bioavailable testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) to assess the integrity of the male reproductive axis and its broader impact on whole-body health. Testosterone is the primary male sex hormone, essential for muscle mass, bone strength, mood, and sexual function. Free testosterone refers to the fraction not bound to proteins, making it immediately available to tissues. Bioavailable testosterone includes both free and loosely bound forms, representing the hormone’s true physiological activity. LH and FSH are pituitary hormones that regulate testicular function—LH stimulates testosterone production, while FSH supports sperm development. Together, these biomarkers reveal how well the hypothalamic-pituitary-gonadal (HPG) axis is functioning. Healthy levels and relationships among testosterone, free T, and Bioavailable T indicate robust androgen signaling, supporting stable mood, metabolism, and reproductive capacity. LH and FSH help distinguish between primary (testicular) and secondary (pituitary or hypothalamic) causes of hypogonadism, clarifying where the system may be disrupted. Interpretation of these results depends on age, time of day, recent illness, medications, and laboratory methods. Testosterone levels naturally decline with age, and acute stress or certain drugs can alter hormone levels. Assay variability between labs can also affect results, so context is essential for accurate assessment.

Frequently Asked Questions

References

  1. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. *The Journal of Clinical Endocrinology & Metabolism*, *103*(5), 1715-1744. https://doi.org/10.1210/jc.2018-00229
  2. Basaria S (2014). Male hypogonadism. *Lancet*, *383*(9924), 1250-1263. https://doi.org/10.1016/S0140-6736(13)61126-5
  3. Agarwal A, Baskaran S, Parekh N, Cho CL, Henkel R, Vij S, Arafa M, Panner Selvam MK, Shah R (2021). Male infertility. *Lancet*, *397*(10271), 319-333. https://doi.org/10.1016/S0140-6736(20)32667-2
  4. Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Han TS, Kula K, Labrie F, Lean MEJ, Pendleton N, Punab M, Vanderschueren D, Huhtaniemi IT, Wu FCW (2010). Characteristics of secondary, primary, and compensated hypogonadism in aging men: Evidence from the European Male Ageing Study. *The Journal of Clinical Endocrinology & Metabolism*, *95*(4), 1810-1818. https://doi.org/10.1210/jc.2009-1796
  5. National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). *Hypogonadism*. https://www.niddk.nih.gov/health-information/endocrine-diseases

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize150+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions - then act, retest, and see what changed.

$349

/year*

150+ biomarkers annually across baseline + retest

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.96 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 150+ biomarkers annually across two blood draws. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments. Then we retest to track your progress and continue refining your plan.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.

What the 100+ panel measures

All 101 markers in your annual baseline draw, organized by system. Nothing here is an upsell.

Heart & Vascular Health

26

  • Apolipoprotein B
  • Atherogenic Coefficient
  • Atherogenic Index of Plasma
  • Castelli Risk Index I
  • Castelli Risk Index II
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL/HDL Ratio
  • Cholesterol, Total
  • Non-HDL Cholesterol
  • Cholesterol/HDL Ratio
  • Carbon Dioxide, Total
  • High-sensitivity CRP
  • hsCRP-to-Albumin Ratio (CAR)
  • GGT-to-HDL Cholesterol Ratio
  • LDL-C to Apolipoprotein B Ratio (LDL-C/ApoB)
  • LDL Cholesterol / Total Cholesterol (Mass Ratio)
  • Monocyte-to-HDL Ratio (MHR)
  • Neutrophil-to-HDL Cholesterol Ratio (NHR)
  • Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)
  • NON-HDL Total Cholesterol Ratio
  • Triglyceride HDL Molar Ratio
  • Triglycerides
  • Triglyceride-to-Apolipoprotein B Ratio (TG/ApoB)
  • TyG Index
  • Uric Acid

Metabolic Health

4

  • Estim. Avg Glu (eAG)
  • Eag (mmol/l)
  • Glucose
  • Hemoglobin A1c

Energy

1

  • Cortisol

Liver Health

15

  • Albumin/Globulin Ratio
  • Albumin
  • Alkaline Phosphatase (ALP)
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)
  • Bilirubin Direct
  • Bilirubin Indirect
  • Bilirubin, Total
  • Bilirubin-to-Albumin Ratio
  • Ferritin
  • Ferritin-to-Albumin Ratio
  • y-Glutamyl Transferase (GGT)
  • Globulin, Total
  • Indirect-to-Direct Bilirubin Ratio
  • Protein, Total

Kidney

11

  • Calcium
  • Chloride
  • Corrected Calcium (Albumin-adjusted)
  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Potassium
  • Sodium
  • BUN/Creatinine Ratio
  • Blood Urea Nitrogen (BUN)
  • Urea-to-Creatinine Ratio
  • Uric Acid-to-HDL Cholesterol Ratio (UHR)

Sex Hormones

7

  • DHEA-Sulfate (DHEA-S)
  • Free Androgen Index
  • Sex Hormone Binding Globulin (SHBG)
  • Free Testosterone
  • Testosterone, Bioavailable
  • Testosterone, Total
  • Testosterone-to-Estradiol Ratio (T/E₂)

Thyroid Health

4

  • Free Thyroxine Index
  • T3 Uptake
  • T4 (thyroxine) Total
  • Thyroid-Stimulating Hormone (TSH)

Nutrients

13

  • Vitamin D
  • Red Cell Dist Width (RDW)
  • Hematocrit
  • Hemoglobin
  • Total Iron Binding Capacity (TIBC)
  • Iron
  • Iron Saturation
  • Mean Cell Hemoglobin (MCH)
  • Mean Corpuscular Hemoglobin Concentration (MCHC)
  • Mean Cell Volume (MCV)
  • Platelet-to-WBC Ratio (PWR)
  • Red Blood Cells
  • RDW MCV Ratio

Immune System

12

  • Basophils
  • Baso (Absolute)
  • Eosinophils
  • Eos (Absolute)
  • Lymphocytes
  • Lymphs (Absolute)
  • Monocytes
  • Monocytes (Absolute)
  • Neutrophils
  • Neutrophils (Absolute)
  • Mean Platelet Volume
  • Platelet Count

Inflammation

8

  • Lymphocyte-to-Monocyte Ratio (LMR)
  • Monocyte-to-Lymphocyte Ratio (MLR)
  • Neutrophil-to-Lymphocyte-Platelet Ratio (NLPR)
  • Neutrophil-to-Lymphocyte Ratio (NLR)
  • Platelet-to-Lymphocyte Ratio (PLR)
  • Systemic Immune-Inflammation Index
  • Systemic Inflammation Response Index (SIRI)
  • White Blood Cells
Get my health baseline

The full list of 100+ markers and 8 specialty add-ons available at superpower.com/what-we-test.